Feedback / Questions
nintedanib inhaled (AP02) - Avalyn Pharma
https://www.globenewswire.com/news-release/2024/08/12/2928335/0/en/Avalyn-Announces-Initiation-of-Phase-1b-Clinical-Study-for-AP02-its-Novel-Inhaled-Nintedanib.html
Aug 12, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next